Recommendations for the management of asthma;Recommandations pour la prise en charge de l'asthme

Revue du Praticien

Volumn 51, Issue 5, 2001, Pages 533-537

  Bousquet, J ^a   Demoly, P ^a   Godard, P ^a  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIASTHMATIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CROMOGLYCATE DISODIUM; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; NEDOCROMIL; THEOPHYLLINE; ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; STEROID;

ASTHMA; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; HUMAN; IMMUNOTHERAPY; MORBIDITY; MORTALITY; PATIENT EDUCATION; PRACTICE GUIDELINE; REVIEW; WORLD HEALTH ORGANIZATION; ARTICLE; DISEASE MANAGEMENT; HEALTH; INTERNATIONAL COOPERATION;

ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; DISEASE MANAGEMENT; HUMANS; IMMUNOTHERAPY; INTERNATIONAL COOPERATION; PATIENT EDUCATION; PRACTICE GUIDELINES; STEROIDS; WORLD HEALTH;

EID: 0035866553     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Guidelines for clinical guidelines
2. Clinical guidelines: Potential benefits, limitations, and harms of clinical guidelines
3. Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group
4. Guidelines for the diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Asthma Education Program. Expert panel report
5. International Consensus Report on Diagnosis and Management of Asthma. International Asthma Management Project
6. Global strategy for asthma management and prevention
7. Stratégie globale pour la guidance de l'asthme et sa prévention ou comment vaincre l'asthme
8. Global Initiative for Asthma (GINA) and its objectives
9. Evidence based medicine: What it is and what it isn't
10. Clinical guidelines: Developing guidelines
11. Systematic reviews and meta-analyses on treatment of asthma: Critical evaluation
12. Evidence based medicine. Cost effectiveness and equity are ignored
13. Physiologic measures: Pulmonary function tests. Asthma outcome
14. Lung function testing: Selection of reference values and interpretative strategies. American Thoracic Society
15. Classification of asthma severity: Should the international guidelines be changed?
16. Diurnal variability-time to change asthma guidelines?
17. House dust mite control measures in the management of asthma: Meta-analysis
18. Immunotherapy in asthma: An updated systematic review
19. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. A WHO position paper
20. Objectives, methods and content of patient education programmes for adults with asthma: Systematic review of studies published between 1979 and 1998
21. Self-management education and regular practitioner review for adults with asthma
22. Asthma. From bronchoconstriction to airways inflammation and remodeling
23. Treatment of asthma with drugs modifying the leukotriene pathway
24. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid
25. Effect of inhaled formoterol and budesonide on exacerbations of asthma
26. The long-term influence of therapeutic interventions in asthma with emphasis on inhaled steroids and early disease
27. An inner-city asthma management initiative. Results of an outcome evaluation
28. End of the New Zealand asthma mortality epidemic
29. Age specific trends in asthma mortality in England and Wales. 1983-95: Results of an observational study
30. Trends in asthma mortality in Australia, 1960-1996
31. Compliance with US asthma management guidelines and specialty care: A regional variation or national concern?
32. Inadequate therapy for asthma among children in the United States